Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli.

The molecular pathogenesis of focal/diffuse proliferative lupus glomerulonephritis was studied by cDNA microarray analysis of gene expression in glomeruli from clinical biopsies. Transcriptional phenotyping of glomeruli isolated by laser-capture microscopy revealed considerable kidney-to-kidney heterogeneity in increased transcript expression, resulting in four main gene clusters that identified the presence of B cells, several myelomonocytic lineages, fibroblast and epithelial cell proliferation, matrix alterations, and expression of type I IFN-inducible genes. Glomerulus-to-glomerulus variation within a kidney was less marked. The myeloid lineage transcripts, characteristic of those found in isolated activated macrophages and myeloid dendritic cells, were widely distributed in all biopsy samples. One major subgroup of the samples expressed fibrosis-related genes that correlated with pathological evidence of glomerulosclerosis; however, decreased expression of TGF-beta1 argued against its role in lupus renal fibrosis. Expression of type I IFN-inducible transcripts by a second subset of samples was associated with reduced expression of fibrosis-related genes and milder pathological features. This pattern of gene expression resembled that exhibited by activated NK cells. A large gene cluster with decreased expression found in all samples included ion channels and transcription factors, indicating a loss-of-function response to the glomerular injury.

[1]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[2]  Kelli Montgomery,et al.  Gene expression in the normal adult human kidney assessed by complementary DNA microarray. , 2003, Molecular biology of the cell.

[3]  Jurg Ott,et al.  A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis , 2003, Nature Genetics.

[4]  Yusuke Nakamura,et al.  An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis , 2003, Nature Genetics.

[5]  M. Madaio,et al.  Short Term Administration of Costimulatory Blockade and Cyclophosphamide Induces Remission of Systemic Lupus Erythematosus Nephritis in NZB/W F1 Mice by a Mechanism Downstream of Renal Immune Complex Deposition1 , 2003, The Journal of Immunology.

[6]  Xuejun Liu,et al.  Comparison of the Changes in Global Gene Expression of Escherichia coli Induced by Four Bactericidal Agents , 2003, Journal of Molecular Microbiology and Biotechnology.

[7]  Hongqing Guo,et al.  Single-Cell Microarray Analysis in Hippocampus CA1: Demonstration and Validation of Cellular Heterogeneity , 2003, The Journal of Neuroscience.

[8]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[9]  M. Requena,et al.  High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon‐α , 2003, American journal of hematology.

[10]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Warrington,et al.  Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis. , 2003, The Journal of molecular diagnostics : JMD.

[12]  Shioko Kimura,et al.  Microarray analysis using amplified mRNA from laser capture microdissection of microscopic hepatocellular precancerous lesions and frozen hepatocellular carcinomas reveals unique and consistent gene expression profiles. , 2003, Toxicologic pathology.

[13]  H. Yamanaka,et al.  Gene expression profiles of human BPH (II): Optimization of laser-capture microdissection and utilization of cDNA microarray. , 2003, Anticancer Research.

[14]  R. Jonsson,et al.  A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans , 2002, Nature Genetics.

[15]  P. Boudinot,et al.  Survey of Transcript Expression in Rainbow Trout Leukocytes Reveals a Major Contribution of Interferon-Responsive Genes in the Early Response to a Rhabdovirus Infection , 2002, Journal of Virology.

[16]  V. D’Agati,et al.  Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy , 2002, Nature Medicine.

[17]  Naftali Kaminski,et al.  Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  L. Klein,et al.  Cutting Edge: Attenuated Experimental Autoimmune Encephalomyelitis in Eta-1/Osteopontin-Deficient Mice1 , 2002, The Journal of Immunology.

[19]  Richard A. Flavell,et al.  Defective Antigen Processing in GILT-Free Mice , 2001, Science.

[20]  T. Behrens,et al.  Delineating the genetic basis of systemic lupus erythematosus. , 2001, Immunity.

[21]  G. Peltz,et al.  Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. , 2001, Immunity.

[22]  N. Willcox,et al.  A role for CD36 in the regulation of dendritic cell function , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Kono,et al.  The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity , 2001, Arthritis research.

[24]  D. Ganten,et al.  Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury. , 2000, Kidney international.

[25]  E. Rondeau,et al.  Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. , 2000, Kidney international.

[26]  G. Sturfelt,et al.  Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies , 2000, Lupus.

[27]  P. Rémy,et al.  A new morphologic index for the evaluation of renal biopsies in lupus nephritis. , 2000, Kidney international.

[28]  Takeshi Suzuki,et al.  Differential Involvement of Src Family Kinases in Fcγ Receptor-Mediated Phagocytosis1 , 2000, The Journal of Immunology.

[29]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[30]  T. Yamamoto,et al.  Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis. , 2000, Journal of immunology.

[31]  Gary A. Churchill,et al.  Analysis of Variance for Gene Expression Microarray Data , 2000, J. Comput. Biol..

[32]  G. Wolf,et al.  Molecular mechanisms of diabetic renal hypertrophy. , 1999, Kidney international.

[33]  G. Crary Heptinstall’s Pathology of the Kidney , 1999 .

[34]  M. Jackson,et al.  Gene expression profiles of laser-captured adjacent neuronal subtypes , 1999, Nature Medicine.

[35]  K. Resch,et al.  IFN‐γ induces the high‐affinity Fc receptor I for IgG (CD64) on human glomerular mesangial cells , 1998 .

[36]  J. Ravetch,et al.  Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. , 1998, Science.

[37]  K. Resch,et al.  IFN-gamma induces the high-affinity Fc receptor I for IgG (CD64) on human glomerular mesangial cells. , 1998, European journal of immunology.

[38]  A. Oshima,et al.  Human IgGFc Binding Protein (FcγBP) in Colonic Epithelial Cells Exhibits Mucin-like Structure* , 1997, The Journal of Biological Chemistry.

[39]  D. Salant,et al.  RANTES and Monocyte Chemoattractant Protein–1 (MCP-1) Play an Important Role in the Inflammatory Phase of Crescentic Nephritis, but Only MCP-1 Is Involved in Crescent Formation and Interstitial Fibrosis , 1997, The Journal of experimental medicine.

[40]  V. D’Agati,et al.  Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides. , 1997, Arthritis and rheumatism.

[41]  D. Boumpas,et al.  High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[42]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[43]  Ronenn Roubenoff,et al.  Arthritis and Allied Conditions: A Textbook of Rheumatology , 1993 .

[44]  D. Lipman,et al.  National Center for Biotechnology Information , 2019, Springer Reference Medizin.

[45]  J. Balow,et al.  Renal disease in systemic lupus erythematosus. , 1988, Rheumatic diseases clinics of North America.

[46]  L R Muenz,et al.  Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. , 1984, Kidney international.

[47]  A. Notkins,et al.  Immune interferon in the circulation of patients with autoimmune disease. , 1979, The New England journal of medicine.

[48]  V. Pollak,et al.  Renal histologic findings in systemic lupus erythematosus. , 1969, Mayo Clinic proceedings.